References
- Bristol-Myers Squibb to acquire celgene to create a premier innovative Biopharma Company. https://ir.celgene.com/press-releases/press-release-details/2019/Bristol-Myers-Squibb-to-Acquire-Celgene-to-Create-a-Premier--Innovative-Biopharma-Company/default.aspx
- Verily announces $1 billion investment round to fund growth and innovation. https://static.googleusercontent.com/media/verily.com/en//press/articles/VerilySilverLake.pdf
- Joining forces to conquer MS. https://give.brighamandwomens.org/stories/2015-bwh-magazine-joining-forces-to-conquer-ms/
- Sensile Medical formed a strategic alliance with Sanofi and Verily to develop and commercialize a connected insulin patch pump. www.sensile-medical.com/fileadmin/user_upload/News_Events/2018/pr-06_2018_alliance-with.pdf
- GSK and Verily to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic medicines. www.gsk.com/en-gb/media/press-releases/gsk-and-verily-to-establish-galvani-bioelectronics-a-new-company-dedicated-to-the-development-of-bioelectronic-medicines/
- Update on our Smart Lens program with Alcon. https://blog.verily.com/2018/11/update-on-our-smart-lens-program-with.html
- Pre-close trading update confirms good progress against 2018 goals. https://ir.q4europe.com/Solutions/VecturaIntranet/3810/newsArticle.aspx?storyid=14175046
- Agenus awarded grant to enable QS-21 innovations. http://investor.agenusbio.com/2019-01-03-Agenus-Awarded-Grant-to-Enable-QS-21-Innovations
- Talee Bio announces $4.5 million award from the Cystic Fibrosis Foundation. http://taleebio.com/cff-press-release/
- Lilly announces agreement to acquire Loxo Oncology. https://investor.lilly.com/news-releases/news-release-details/lilly-announces-agreement-acquire-loxo-oncology
- Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinson's Disease and Friedreich's Ataxia. www.globenewswire.com/news-release/2019/01/29/1706690/0/en/Neurocrine-Biosciences-and-Voyager-Therapeutics-Form-Strategic-Development-and-Commercialization-Collaboration-for-Parkinson-s-Disease-and-Friedreich-s-Ataxia.html
- Biogen and Skyhawk Therapeutics announce agreement to develop novel small molecule rna splicing modifiers for neurological disease targets. http://investors.biogen.com/news-releases/news-release-details/biogen-and-skyhawk-therapeutics-announce-agreement-develop-nove
- Biogen and C4 Therapeutics enter into strategic collaboration to discover and develop potential new treatments for neurological conditions. http://investors.biogen.com/news-releases/news-release-details/biogen-and-c4-therapeutics-enter-strategic-collaboration
- Proteus Digital Health® launches digital oncology medicines to improve patient outcomes. www.proteus.com/press-releases/proteus-digital-health-launches-digital-oncology-medicines-to-improve-patient-outcomes/
- Otsuka and Click Therapeutics collaborate to develop and commercialize digital therapeutics for patients with major depressive disorder. www.businesswire.com/news/home/20190103005147/en/Otsuka-Click-Therapeutics-Collaborate-Develop-Commercialize-Digital
- Mylan announces FDA approval of Wixela™ Inhub™ (fluticasone propionate and salmeterol inhalation powder, USP), first generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder). http://newsroom.mylan.com/2019-01-31-Mylan-Announces-FDA-Approval-of-Wixela-TM-Inhub-TM-fluticasone-propionate-and-salmeterol-inhalation-powder-USP-First-Generic-of-ADVAIR-DISKUS-R-fluticasone-propionate-and-salmeterol-inhalation-powder
- Long-acting contraceptive designed to be self-administered via microneedle patch. www.rh.gatech.edu/news/616313/long-acting-contraceptive-designed-be-self-administered-microneedle-patch
- Engineers create an inhalable form of messenger RNA. www.sciencedaily.com/releases/2019/01/190104104032.htm
- Translate Bio advances programs in cystic fibrosis (CF) and ornithine transcarbamylase (OTC) deficiency. https://investors.translate.bio/news-releases/news-release-details/translate-bio-advances-programs-cystic-fibrosis-cf-and-ornithine
- Patel AK , KaczmarekJC , BoseSet al. Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium. Adv. Mater.31(8), 1805116 (2019).
- Bioinspired nanoscale drug delivery method developed by WSU, PNNL researchers. https://news.wsu.edu/2019/01/10/nanoscale-drug-delivery-method-developed-wsu-researchers/
- In surprising reversal, scientists find a cellular process that stops cancer before it starts. www.sciencedaily.com/releases/2019/01/190123131706.htm
- Gene therapy blocks peripheral nerve damage in mice. https://source.wustl.edu/2019/01/gene-therapy-blocks-peripheral-nerve-damage-in-mice/
- Geisler S , HuangSX , StricklandAet al. Gene therapy targeting SARM1 blocks pathological axon degeneration in mice. J. Exp. Med.216(2), 294 (2019).